about
sameAs
Osteoprotegerin levels in patients with severe mental disordersSimilar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factorInterleukin 1 receptor antagonist and soluble tumor necrosis factor receptor 1 are associated with general severity and psychotic symptoms in schizophrenia and bipolar disorderMedical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trialIncreased systemic and myocardial expression of neutrophil gelatinase-associated lipocalin in clinical and experimental heart failureExcessive innate immune response and mutant D222G/N in severe A (H1N1) pandemic influenza.Prognostic value of changes in galectin-3 levels over time in patients with heart failure: data from CORONA and COACH.Myocardial expression of CC- and CXC-chemokines and their receptors in human end-stage heart failure.Restoration of the coupling process and normalization of bone mass following successful treatment of endogenous Cushing's syndrome: a prospective, long-term study.Peripheral endothelial dysfunction in heart transplant recipients: possible role of proinflammatory cytokines.Vitamin D Status and Long-Term Mortality in Community-Acquired Pneumonia: Secondary Data Analysis from a Prospective Cohort.The effect of rosuvastatin on inflammation, matrix turnover and left ventricular remodeling in dilated cardiomyopathy: a randomized, controlled trial.Interaction between chemokines and oxidative stress: possible pathogenic role in acute coronary syndromes.Effect of metoprolol on cytokine levels in chronic heart failure--a substudy in the Metoprolol Controlled-Release Randomised Intervention Trial in Heart Failure (MERIT-HF).Differences in insulin sensitivity, lipid metabolism and inflammation between young adult Pakistani and Norwegian patients with type 2 diabetes: a cross sectional study.Associations of brain-natriuretic peptide, high-sensitive troponin T, and high-sensitive C-reactive protein with outcomes in severe aortic stenosis.Wnt5a is associated with right ventricular dysfunction and adverse outcome in dilated cardiomyopathyFavorable long-term effects of growth hormone replacement therapy on quality of life, bone metabolism, body composition and lipid levels in patients with adult-onset growth hormone deficiency.Fatty Acid binding protein 4 is associated with carotid atherosclerosis and outcome in patients with acute ischemic strokeThe homeostatic chemokine CCL21 predicts mortality and may play a pathogenic role in heart failure.Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).Increased levels of inflammatory cytokines and endothelin-1 in alveolar macrophages from patients with chronic heart failure.Efficacy of high intensity exercise on disease activity and cardiovascular risk in active axial spondyloarthritis: a randomized controlled pilot studyPredictors of exacerbations in chronic obstructive pulmonary disease--results from the Bergen COPD cohort study.Systemic biomarkers of inflammation and haemostasis in patients with chronic necrotizing pulmonary aspergillosisA complex interaction between Rickettsia conorii and Dickkopf-1--potential role in immune evasion mechanisms in endothelial cells.Serum levels of osteoprotegerin and receptor activator of nuclear factor -κB ligand in children with early juvenile idiopathic arthritis: a 2-year prospective controlled study.Beta cell function after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle interventionUmbilical cord levels of sclerostin, placental weight, and birth weight are predictors of total bone mineral content in neonates.The homeostatic chemokine CCL21 predicts mortality in aortic stenosis patients and modulates left ventricular remodeling.CCL21 is associated with fatal outcomes in chronic heart failure: data from CORONA and GISSI-HF trials.High frequency and intensity of drinking may attenuate increased inflammatory cytokine levels of major depression in alcohol-use disorders.Characterization of cytomegalovirus disease in solid organ transplant recipients by markers of inflammation in plasma.Association of ficolin-3 with severity and outcome of chronic heart failure.Cytokine network in adults with falciparum Malaria and HIV-1: increased IL-8 and IP-10 levels are associated with disease severity.Thioredoxin interacting protein is a potential regulator of glucose and energy homeostasis in endogenous Cushing's syndrome.Attenuated RORC expression in the presence of EMT progression in somatotroph adenomas following treatment with somatostatin analogs is associated with poor clinical recoveryIncreased systemic and local interleukin 9 levels in patients with carotid and coronary atherosclerosisInflammation markers in multiple sclerosis: CXCL16 reflects and may also predict disease activityCirculating dickkopf-1 in diabetes mellitus: association with platelet activation and effects of improved metabolic control and low-dose aspirin.
P50
Q24626094-8FA3797E-A747-42FC-90E1-C9A510EAA744Q28261811-986D6079-431A-4C5F-91B4-E926F8051B2CQ28285454-F8FFF244-D5C6-40F3-AF63-CE37B2953320Q28287136-784E0AB5-9037-4C5A-8336-77C7D07A1551Q28575465-400DF357-C0BE-4D56-91BF-9389D98A0520Q30405122-629D7FBD-2F78-4CB9-8B11-205DB2CB7AD8Q30587543-A3690E15-FEE5-4970-86C4-6817D5AE20F4Q30611192-5032F0D4-8C5A-4CBC-9582-32401DCB61CEQ30805167-7C46CEF2-767B-4E03-BF91-B80CECCACF7CQ30873807-72ADE883-DF89-43CB-A914-B9755B3FA283Q31111834-FB913F36-FECD-4050-B13D-710EC79B1F5FQ31152172-806714E7-E4E4-4B17-8FC9-EBED192A2983Q32055041-F756C83A-37A0-49B6-85BE-291E7481E1E6Q32083263-D4A1272B-E3D0-45B0-9E3D-AF22E3353D34Q33589324-F18F51CB-47CE-4F77-BC69-040AC4580564Q33788258-1C5E28B5-B669-439A-A191-8214B5DB9EDAQ33799421-32050B49-753F-4C99-9609-182D2198045DQ33812338-078965B1-7DAD-4633-BD3E-2409EAEE47DCQ34103370-340A03F6-3D34-4922-91AA-D439A88C2628Q34200352-C6521CD2-B131-471E-B2AB-E556F7E49ACAQ34269132-6EBA419B-F9ED-4767-B930-A605FF139535Q34277432-84CA9FE2-A0C7-4B9D-AB3D-A854E7719116Q34277511-CB6B2EB1-88E4-4CAC-BAE7-9EF18DB57E05Q34287563-639A8A3D-49FD-4CCA-B5B5-9115047C50C2Q34316549-C296374E-223F-4117-862F-01016517FB1FQ34426813-68AF06F0-54DC-45FB-ACFD-45277DA3AD73Q34461706-9680DDCA-A351-4186-8C27-2F4BFDF45A90Q34497673-475768B9-9985-4CFE-B8C5-3BB58620D54FQ34503776-2DCC313B-968A-4052-A69C-CA8B5BDB1F8DQ34513415-138D86C7-DFAB-4589-B289-652461F9303FQ34619812-D18D0F14-BDCC-40FA-83F6-2660436581B4Q34637905-63BF2828-7DD6-4493-8C4C-290265CDF46DQ34674064-48877774-A00E-43EA-8744-460E5AF9FB4BQ34676160-152D2D94-E825-4ED8-90F6-062FF28A9B19Q34682109-E074AD42-589D-411D-A9A5-78EFAF10A81BQ34731377-B2616581-6E04-4A77-A47F-ABD8F8712283Q34794452-BAF0ABB8-DF8E-4261-BBA4-FEE87C9C442CQ34983608-47409971-8706-4B43-ADF6-E83B3B118C4DQ34999439-293331C4-2082-4CDE-84DB-C0570C21D72FQ35026334-867B40A4-55B8-411B-89CD-D669B0D7EC47
P50
description
Noors wetenschapper
@nl
científicu noruegu
@ast
norwegischer Wissenschaftler
@de
researcher ORCID ID = 0000-0001-5005-0784
@en
name
Thor Ueland
@ast
Thor Ueland
@ca
Thor Ueland
@de
Thor Ueland
@en
Thor Ueland
@es
Thor Ueland
@fr
Thor Ueland
@ga
Thor Ueland
@it
Thor Ueland
@nb
Thor Ueland
@nl
type
label
Thor Ueland
@ast
Thor Ueland
@ca
Thor Ueland
@de
Thor Ueland
@en
Thor Ueland
@es
Thor Ueland
@fr
Thor Ueland
@ga
Thor Ueland
@it
Thor Ueland
@nb
Thor Ueland
@nl
prefLabel
Thor Ueland
@ast
Thor Ueland
@ca
Thor Ueland
@de
Thor Ueland
@en
Thor Ueland
@es
Thor Ueland
@fr
Thor Ueland
@ga
Thor Ueland
@it
Thor Ueland
@nb
Thor Ueland
@nl
P106
P21
P214
2494149108553568780000
P27
P31
P496
0000-0001-5005-0784
P569
1969-08-03T00:00:00Z
P734
P735
P7859
viaf-2494149108553568780000